Close
9 January 2026

We launched the HUB Alzheimer Barcelona scientific sessions cycle with "The Omics of the HUB"

Bimonthly sessions to strengthen collaboration between institutions, showcase emerging talent and promote knowledge exchange in the field of Alzheimer's in Barcelona.
We launched the cycle of scientific sessions of the Alzheimer HUB Barcelona with a first topic: "The omics of the HUB"

On January 9, 2026, the first scientific session of the Alzheimer HUB Barcelonatook place, marking the beginning of the HUB's Scientific Sessions Cycle.

Held every two months and with a rotating venue among the different centres that make up the HUB, this initiative aims to foster mutual understanding between clinical and research teams, promote synergies and potential collaborations in ongoing projects, offer predoctoral and postdoctoral researchers a platform to present emerging research and build a cohesive and dynamic scientific ecosystem in the field of Alzheimer's disease and other related dementias.

The inaugural session, held in Ace Alzheimer Center Barcelona, focused on the HUB's research in omics sciences, one of the most transformative areas for understanding the mechanisms of Alzheimer's disease and other related pathologies, as well as for opening new avenues of diagnosis and treatment.

The day began with the institutional welcome by Dr Mercè Boada, co-founder and medical director of Ace Alzheimer Center Barcelona, followed by the presentation of the HUB by its Alliance Manager, the Dr. Carla Obradors-Tarragó, and was moderated by Dr. Victoria Fernández, responsible for Ace's genetics programme.

During the session, we had four high-level presentations given by young researchers who explained their innovative projects in different areas of omics sciences applied to Alzheimer's:

  • “Long runs of Homozygosity associated with Alzheimer's Disease”, Claudia Olivé (Ace Alzheimer Center Barcelona).
  • “RNA-seq in Alzheimer's Disease organoids”, Andrea Martí (BarcelonaBeta Brain Research Center).
  • “Proteomic analysis in Alzheimer's Disease and Other Dementias: A Focus on Sex-specific Differences”, Aina Comas (Hospital Clínic Barcelona / IDIBAPS).
  • “Role of synaptic miRNA in Alzheimer's disease”, Dr. Laia Llidón (Hospital de Sant Pau).

The session included the participation of more than 30 attendees and took place in a scientific, friendly and relaxed environment that fostered the exchange of ideas, debate and networking among the participants.

Close
Image
Image
Image
Image
Image
Image